Synovus Financial’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $147K | Sell |
44,690
-4,375
| -9% | -$12.4K | ﹤0.01% | 923 |
|
|
2025
Q2 | $69.7K | Hold |
49,065
| – | – | ﹤0.01% | 903 |
|
|
2025
Q1 | $73.1K | Hold |
49,065
| – | – | ﹤0.01% | 884 |
|
|
2024
Q4 | $55K | Sell |
49,065
-49,065
| -50% | -$41.9K | ﹤0.01% | 863 |
|
|
2024
Q3 | $92.9K | Buy |
98,130
+49,065
| +100% | +$61.9K | ﹤0.01% | 896 |
|
|
2024
Q2 | $77.5K | Hold |
49,065
| – | – | ﹤0.01% | 833 |
|
|
2024
Q1 | $71.1K | Hold |
49,065
| – | – | ﹤0.01% | 836 |
|
|
2023
Q4 | $65.7K | Hold |
49,065
| – | – | ﹤0.01% | 813 |
|
|
2023
Q3 | $69.7K | Sell |
49,065
-55,000
| -53% | -$78K | ﹤0.01% | 825 |
|
|
2023
Q2 | $120K | Hold |
104,065
| – | – | ﹤0.01% | 820 |
|
|
2023
Q1 | $110K | Buy |
104,065
+55,000
| +112% | +$79.3K | ﹤0.01% | 808 |
|
|
2022
Q4 | $74.6K | Hold |
49,065
| – | – | ﹤0.01% | 841 |
|
|
2022
Q3 | $104K | Buy |
49,065
+5,000
| +11% | +$10.5K | ﹤0.01% | 825 |
|
|
2022
Q2 | $59K | Sell |
44,065
-7,625
| -15% | -$11.3K | ﹤0.01% | 830 |
|
|
2022
Q1 | $109K | Buy |
51,690
+12,000
| +30% | +$29.2K | ﹤0.01% | 828 |
|
|
2021
Q4 | $147K | Buy |
39,690
+9,800
| +33% | +$42.2K | ﹤0.01% | 840 |
|
|
2021
Q3 | $149K | Hold |
29,890
| – | – | ﹤0.01% | 820 |
|
|
2021
Q2 | $195K | Hold |
29,890
| – | – | ﹤0.01% | 807 |
|
|
2021
Q1 | $206K | Buy |
+29,890
| New | +$253K | ﹤0.01% | 717 |
|
|
2020
Q1 | – | Sell |
-1,000
| Closed | -$5K | – | 2204 |
|
|
2019
Q4 | $5K | Sell |
1,000
-3,000
| -75% | -$16.9K | ﹤0.01% | 1313 |
|
|
2019
Q3 | $23K | Hold |
4,000
| – | – | ﹤0.01% | 1062 |
|
|
2019
Q2 | $31K | Sell |
4,000
-18,188
| -82% | -$97.9K | ﹤0.01% | 931 |
|
|
2019
Q1 | $116K | Hold |
22,188
| – | – | ﹤0.01% | 673 |
|
|
2018
Q4 | $146K | Hold |
22,188
| – | – | ﹤0.01% | 612 |
|
|
2018
Q3 | $382K | Hold |
22,188
| – | – | 0.01% | 492 |
|
|
2018
Q2 | $309K | Hold |
22,188
| – | – | 0.01% | 505 |
|
|
2018
Q1 | $340K | Sell |
22,188
-10,000
| -31% | -$143K | 0.01% | 482 |
|
|
2017
Q4 | $371K | Sell |
32,188
-1,225
| -4% | -$18.2K | 0.01% | 462 |
|
|
2017
Q3 | $635K | Sell |
33,413
-200
| -0.6% | -$4.12K | 0.01% | 371 |
|
|
2017
Q2 | $810K | Buy |
33,613
+200
| +0.6% | +$4.39K | 0.02% | 332 |
|
|
2017
Q1 | $662K | Sell |
33,413
-301
| -0.9% | -$6.72K | 0.01% | 319 |
|
|
2016
Q4 | $812K | Buy |
+33,714
| New | +$938K | 0.02% | 287 |
|
Other funds holding PGEN
PCM
TCM
IAM
OCM
Synovus Financial's PGEN Position: Q3 2025 in Review
Synovus Financial reduced its Precigen (PGEN) stake by 8.9% in Q3 2025, selling an estimated $12.4K and leaving 44,690 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #923.
Synovus Financial first reported a position in PGEN in Q4 2016 and has held it in 32 quarters since. The position peaked at $812K in Q4 2016. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.
- Synovus Financial held 44,690 shares of Precigen worth $147K as of Q3 2025.
- Synovus Financial sold 4,375 Precigen shares in Q3 2025, an estimated $12.4K.
- Precigen made up ﹤0.01% of Synovus Financial's portfolio in Q3 2025, its #923 holding.
- Synovus Financial first reported a position in Precigen in Q4 2016 and has held it in 32 quarters since.
- Synovus Financial's Precigen position peaked at $812K in Q4 2016.
- 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.
Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.